Valley Interfaith in favor of Proposition 1

Translate to Spanish or other 102 languages!

Hidalgo County— Valley Interfaith in conjunction with Project VIDA will announce their endorsement of Proposition 1.

- Advertisement -

The organization says the hospital district will help the most vulnerable members of the community receive the healthcare services they need.

“There are so many reasons to support the creation of the hospital district, support Proposition 1. It is going to mean better access to healthcare and more clinics,” Valley Interfaith leader Eddie Anaya, said. “For every dollar invested, the federal government will match that dollar with $1.50. By leveraging our local monies, we can access millions of dollars and we won’t lose them to other counties.”

The organization plans to block walk in support of Proposition 1 and get the message out during Sunday mass at numerous churches across Hidalgo County.

- Advertisement -

Valley Interfaith is a broad based organization of over 25 institutions valley wide that works to develop community leaders so that our parishioners and families have a continuing voice and say in matters directly affecting their communities. We are strictly non-partisan and do not endorse political candidates.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

DSHS Confirms First West Nile Case in Texas in 2026

The Texas Department of State Health Services is reporting this year’s first case of West Nile illness in a resident of Harris County. Health officials confirmed the resident was diagnosed with West Nile virus neuroinvasive disease. 
- Advertisement -